These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9618429)

  • 1. Long-acting blockade of biogenic amine transporters in rat brain by administration of the potent novel tropane 2beta-propanoyl-3beta-(2-Naphthyl)-tropane.
    Daunais JB; Hart SL; Smith HR; Letchworth SR; Davies HM; Sexton T; Bennett BA; Childers SR; Porrino LJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1246-54. PubMed ID: 9618429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged dopamine and serotonin transporter inhibition after exposure to tropanes.
    Bennett BA; Hollingsworth CK; Martin RS; Childers SR; Ehrenkaufer RE; Porrino LJ; Davies HM
    Neuropharmacology; 1998; 37(1):123-30. PubMed ID: 9680265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in behavior and opioid gene expression induced by the novel tropane analog WF-31.
    Daunais JB; Hart SL; Hedgecock-Rowe A; Matasi JJ; Thornley C; Davies HM; Porrino LJ
    Brain Res Mol Brain Res; 1997 Oct; 50(1-2):293-304. PubMed ID: 9406946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term biogenic amine transporter blockade on receptor/G-protein coupling in rat brain.
    O'Connor KA; Gregg TC; Davies HM; Childers SR
    Neuropharmacology; 2005 Jan; 48(1):62-71. PubMed ID: 15617728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes in receptor/G-protein coupling in rat brain following chronic monoamine transporter blockade.
    O'Connor KA; Porrino LJ; Davies HM; Childers SR
    J Pharmacol Exp Ther; 2005 May; 313(2):510-7. PubMed ID: 15644432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo characterization of a novel phenylisothiocyanate tropane analog at monoamine transporters in rat brain.
    Murthy V; Martin TJ; Kim S; Davies HM; Childers SR
    J Pharmacol Exp Ther; 2008 Aug; 326(2):587-95. PubMed ID: 18492949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters.
    Hemby SE; Lucki I; Gatto G; Singh A; Thornley C; Matasi J; Kong N; Smith JE; Davies HM; Dworkin SI
    J Pharmacol Exp Ther; 1997 Aug; 282(2):727-33. PubMed ID: 9262336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain.
    Letchworth SR; Smith HR; Porrino LJ; Bennett BA; Davies HM; Sexton T; Childers SR
    J Pharmacol Exp Ther; 2000 May; 293(2):686-96. PubMed ID: 10773045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
    Bennett BA; Wichems CH; Hollingsworth CK; Davies HM; Thornley C; Sexton T; Childers SR
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1176-86. PubMed ID: 7891330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
    Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes.
    Silverthorn ML; Dersch CM; Baumann MH; Cadet JL; Partilla JS; Rice KC; Carroll FI; Becketts KM; Brockington A; Rothman RB
    J Pharmacol Exp Ther; 1995 Apr; 273(1):213-22. PubMed ID: 7714769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local cerebral metabolic effects of the novel cocaine analog, WF-31: comparisons to fluoxetine.
    Porrino LJ; Miller M; Hedgecock AA; Thornley C; Matasi JJ; Davies HM
    Synapse; 1997 Sep; 27(1):26-35. PubMed ID: 9268062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
    Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
    J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter.
    Hiranita T; Wilkinson DS; Hong WC; Zou MF; Kopajtic TA; Soto PL; Lupica CR; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2014 May; 349(2):297-309. PubMed ID: 24518035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the behavioral effects of the repeated administration of PTT, 2beta-propanoyl-3beta-(4-tolyl)tropane and cocaine.
    Freedland CS; Smith HR; Hart SL; Daunais JB; Davies HM; Porrino LJ
    Brain Res; 2000 Jun; 869(1-2):98-104. PubMed ID: 10865063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cocaine analog, 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT), reduces tyrosine hydroxylase in the mesolimbic dopamine pathway.
    Freeman WM; Yohrling GJ; Daunais JB; Gioia L; Hart SL; Porrino LJ; Davies HM; Vrana KE
    Drug Alcohol Depend; 2000 Dec; 61(1):15-21. PubMed ID: 11064180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics.
    Lile JA; Wang Z; Woolverton WL; France JE; Gregg TC; Davies HM; Nader MA
    J Pharmacol Exp Ther; 2003 Oct; 307(1):356-66. PubMed ID: 12954808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of the novel tropane analog, 2 beta-propanoyl-3 beta-(4-toluyl)-tropane (PTT).
    Porrino LJ; Migliarese K; Davies HM; Saikali E; Childers SR
    Life Sci; 1994; 54(26):PL511-7. PubMed ID: 8208059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.